179 related articles for article (PubMed ID: 29463803)
1. ALCAM
Zhou Z; Li Y; Wang X; Hu J; Kuang M; Wang Z; Li S; Xu W; Xiao J
Cell Death Dis; 2018 Feb; 9(3):299. PubMed ID: 29463803
[TBL] [Abstract][Full Text] [Related]
2. Enrichment of c-Met+ tumorigenic stromal cells of giant cell tumor of bone and targeting by cabozantinib.
Liu L; Aleksandrowicz E; Fan P; Schönsiegel F; Zhang Y; Sähr H; Gladkich J; Mattern J; Depeweg D; Lehner B; Fellenberg J; Herr I
Cell Death Dis; 2014 Oct; 5(10):e1471. PubMed ID: 25321478
[TBL] [Abstract][Full Text] [Related]
3. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
Chen F; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J; Xia J
Biomed Pharmacother; 2018 Jul; 103():1092-1100. PubMed ID: 29710674
[TBL] [Abstract][Full Text] [Related]
4. Biological characteristics of a novel giant cell tumor cell line derived from spine.
Zhou Z; Li Y; Xu L; Wang X; Chen S; Yang C; Xiao J
Tumour Biol; 2016 Jul; 37(7):9681-9. PubMed ID: 26801673
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of reduced connexin43 expression and gap junction coupling of neoplastic stromal cells in giant cell tumor of bone.
Balla P; Maros ME; Barna G; Antal I; Papp G; Sapi Z; Athanasou NA; Benassi MS; Picci P; Krenacs T
PLoS One; 2015; 10(5):e0125316. PubMed ID: 25933380
[TBL] [Abstract][Full Text] [Related]
6. Stro-1(+) stromal cells have stem-like features in giant cell tumor of bone.
Lan J; Liu X; Rong W; Wei F; Jiang L; Yu H; Dang G; Liu Z
J Surg Oncol; 2012 Dec; 106(7):826-36. PubMed ID: 22605660
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone.
Balla P; Moskovszky L; Sapi Z; Forsyth R; Knowles H; Athanasou NA; Szendroi M; Kopper L; Rajnai H; Pinter F; Petak I; Benassi MS; Picci P; Conti A; Krenacs T
Histopathology; 2011 Sep; 59(3):376-89. PubMed ID: 22034878
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-210 is upregulated by hypoxia-inducible factor-1α in the stromal cells of giant cell tumors of bone.
Guo S; Bai R; Liu W; Zhao A; Zhao Z; Wang Y; Wang Y; Zhao W; Wang W
Mol Med Rep; 2015 Oct; 12(4):6185-92. PubMed ID: 26239498
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin Possesses Antitumor and Differentiation-Promoting Properties That Affect Stromal Cells in Giant Cell Tumor of Bone.
Lau CPY; Fung CSH; Wong KC; Wang YH; Huang L; Tsui SKW; Lee OK; Kumta SM
J Orthop Res; 2020 Feb; 38(2):297-310. PubMed ID: 31471919
[TBL] [Abstract][Full Text] [Related]
10. IL-17A stimulates the progression of giant cell tumors of bone.
Xu M; Song ZG; Xu CX; Rong GH; Fan KX; Chen JY; Zhang W; Jia JP; Han G; Wang W; Chai W; Liang WT; Bi WZ; Wang Y
Clin Cancer Res; 2013 Sep; 19(17):4697-705. PubMed ID: 23857601
[TBL] [Abstract][Full Text] [Related]
11. Stromal Cell-Derived CCL20 Promotes Tumor Progression and Osteolysis in Giant Cell Tumor of Bone.
Zhao C; Wang D; Tang L; Zhang Z; Li S; Qian M; Wu Z; Zhou W; Liu M; Luo J; Liu T; Li Z; Xiao J
Cell Physiol Biochem; 2018; 51(5):2472-2483. PubMed ID: 30537747
[TBL] [Abstract][Full Text] [Related]
12. Denosumab Induces Neoplastic Stromal Cell Apoptosis
Chen X; Ye F; He H; Chen G; Chen Z; Ye E; He B; Yang Y; Zhang J
Curr Cancer Drug Targets; 2024; 24(5):565-578. PubMed ID: 37961860
[TBL] [Abstract][Full Text] [Related]
13. Serglycin induces osteoclastogenesis and promotes tumor growth in giant cell tumor of bone.
He Y; Cheng D; Lian C; Liu Y; Luo W; Wang Y; Ma C; Wu Q; Tian P; He D; Jia Z; Lv X; Zhang X; Pan Z; Lu J; Xiao Y; Zhang P; Liang Y; Yang Q; Hu G
Cell Death Dis; 2021 Sep; 12(10):868. PubMed ID: 34556636
[TBL] [Abstract][Full Text] [Related]
14. Activated leukocyte cell-adhesion molecule (ALCAM) promotes malignant phenotypes of malignant mesothelioma.
Ishiguro F; Murakami H; Mizuno T; Fujii M; Kondo Y; Usami N; Yokoi K; Osada H; Sekido Y
J Thorac Oncol; 2012 May; 7(5):890-9. PubMed ID: 22722789
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
[TBL] [Abstract][Full Text] [Related]
16. Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells.
Fellenberg J; Sähr H; Mancarella D; Plass C; Lindroth AM; Westhauser F; Lehner B; Ewerbeck V
Cancer Lett; 2019 Apr; 448():61-69. PubMed ID: 30742944
[TBL] [Abstract][Full Text] [Related]
17. The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker.
Darvishi B; Boroumandieh S; Majidzadeh-A K; Salehi M; Jafari F; Farahmand L
Exp Mol Pathol; 2020 Aug; 115():104443. PubMed ID: 32380056
[TBL] [Abstract][Full Text] [Related]
18. The role of the tumor suppressor RUNX3 in giant cell tumor of the bone.
Han YX; Liang DY
Int J Oncol; 2012 Mar; 40(3):673-8. PubMed ID: 22076387
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
[TBL] [Abstract][Full Text] [Related]
20. Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis.
van Kempen LC; Meier F; Egeblad M; Kersten-Niessen MJ; Garbe C; Weidle UH; Van Muijen GN; Herlyn M; Bloemers HP; Swart GW
J Invest Dermatol; 2004 May; 122(5):1293-301. PubMed ID: 15140234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]